SynbiTECH2020 - Sponsor or Exhibit?
- Posted on 7 January
Your opportunity to sponsor and exhibit at Europe's leading synthetic biology conference and technology showcase in July 2020
Happy new year! 2020 is the start of a new decade in which synthetic biology will thrive and grow – by 2030 we expect the global marketplace to be at least $100bn.
After the great success of our SynbiTECH conference, technology showcase and exhibition in 2019, we’re running a bigger and even better SynbiTECH in 2020; I’m emailing again with further details on SynbiTECH 2020 – opportunities are going fast!
SynbiTECH2020 will attract leading synthetic biology and related companies from around the world, more than 600 visitors are expected from academics to start-ups and global businesses who work in and within the engineering of biology fields creating new tools, services, processes and products for this massively-growing new industry.
I’ve attached Adobe links to our prospectus with details of the forthcoming conference and a booking form so that you can sign-up straight away! One immediate difference you’ll spot is that each sponsorship opportunity comes with a technology showcase exhibition space.
There are speaking opportunities too – for further details or to chat about your needs at SynbiTECH2020 please don’t hesitate to drop me a line or give me a call , my details are shown below and on the prospectus.
Share this article:
People also read
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food
An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...
Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer
Macrophage Pharma Limited ("MPL"), a biotech company focused on the discovery and development of next-generation immunomodulatory small molecules indu...